FDA Approves TransPyloric Shuttle Intragastric Device for Obesity – MedScape

Read article - Quotes Richard Rothstein, the Joseph M. Huber Professor of Medicine and chair of the Department of Medicine, about how the U.S. Food and Drug Administration (FDA) has approved the TransPyloric Shuttle (TPS) intragastric device to help eligible obese patients lose weight. (Similar coverage in Compleo.)